Edition:
United States

CSL Ltd (CSL.AX)

CSL.AX on Australia Stock Exchange

130.11AUD
26 Apr 2017
Change (% chg)

$1.52 (+1.18%)
Prev Close
$128.59
Open
$129.50
Day's High
$130.40
Day's Low
$129.00
Volume
1,029,616
Avg. Vol
987,842
52-wk High
$130.40
52-wk Low
$91.62

CSL.AX

Chart for CSL.AX

About

CSL Limited is a biotherapeutics company that develops and delivers biotherapies. The Company's principal activities are research, development, manufacture, marketing and distribution of biopharmaceutical and allied products. Its segments include CSL Behring, Seqirus and CSL Intellectual Property. The CSL Behring segment... (more)

Overall

Beta: 0.79
Market Cap(Mil.): $58,471.39
Shares Outstanding(Mil.): 454.71
Dividend: 0.84
Yield (%): 1.34

Financials

  CSL.AX Industry Sector
P/E (TTM): 33.55 29.15 30.27
EPS (TTM): 3.83 -- --
ROI: 20.17 13.65 13.24
ROE: 46.20 14.61 14.40

BRIEF-Momenta Pharmaceuticals announces HSR clearance

* Momenta Pharmaceuticals announces Hart-Scott-Rodino clearance for collaboration and license agreement with CSL

Feb 17 2017

BRIEF-CSL Ltd updates on outlook

* "Group's net profit after tax (NPAT) is expected to grow in range of approximately 18 to 20% at constant currency"

Feb 14 2017

Australia shares rise as CSL surges, materials gain; NZ flat

Jan 19 CSL Ltd drove gains in the Australian benchmark on Thursday, surging after it upgraded its annual profit guidance, while materials and financials also added to the uptrend.

Jan 18 2017

More From Around the Web

Earnings vs. Estimates